Vaccine News and Research

Latest Vaccine News and Research

New findings show the potential for language to enhance trust in COVID-19 vaccines

A simple language intervention has the potential to boost COVID-19 vaccination rates, by strengthening trust in the vaccines, researchers say.

19 Jan 2022

Study reveals the experience of support health care workers from underserved communities during COVID-19

A Rutgers study gives new insight into the experiences and perspectives of Black and Latinx people working in supportive health care roles during the COVID-19 pandemic.

18 Jan 2022

"Nocebo effect" accounts for 76% of all adverse events in the COVID-19 vaccine trial group

The placebo effect is the well-known phenomenon of a person's physical or mental health improving after taking a treatment with no pharmacological therapeutic benefit – a sugar pill, or a syringe full of saline, for example.

18 Jan 2022

Three doses Of Pfizer-BioNTech vaccine could offer sufficient level of protection from Omicron

A new study that evaluated the effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine against the Omicron variant indicates that three doses could offer a sufficient level of protection from disease caused by the Omicron variant.

18 Jan 2022

Parents of children hospitalized in NICU during the pandemic report emotional exhaustion and isolation

Emotional exhaustion, isolation and “nonsensical” visitor and other hospital policies contributed to parents of children hospitalized in neonatal intensive care units feeling less satisfied with care during the early days of COVID-19.

18 Jan 2022

Study finds COVID booster maintains strong T cell response against Omicron

New study results posted to the medRxiv* preprint server found that COVID vaccine boosters increase immunity by enhancing T cell immune memory. In the face of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) Omicron variant, vaccinated people who had received a third booster shot maintained high T cell responses than people with naturally acquired immunity or vaccine-induced immunity from two doses of the SARS‑CoV‑2 vaccine.

18 Jan 2022

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

A recent article published in the journal Science explains how SARS-CoV-2 variants can bypass vaccine-induced immune defenses. However, immunity is restorable with a booster shot. The paper's authors outlined the importance of a booster shot in maintaining immunity and preventing severe infection.

18 Jan 2022

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

In a new study, a team of researchers compared the severity of the SARS-CoV-2 Omicron variant to the Delta variant using the PCR proxy marker of RNA dependent RNA polymerase target delay.

18 Jan 2022

Dynamics of outbreaks of SARS-CoV-2 variants of concern

In a new study, researchers characterized the features of the outbreak duration of the novel SARS-CoV-2 variants of concern.

18 Jan 2022

Exploring the waning effect of mRNA vaccines against COVID-19 in the elderly

In a new study, researchers determined the vaccine effectiveness against SARS-CoV-2 in older individuals.

18 Jan 2022

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

In a new study, researchers analyzed the neutralization of SARS-CoV-2 Omicron and D614G variants before and after subjects received COVID-19 booster vaccinations.

18 Jan 2022

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

The authors highlight that they have shown that boosted individuals are significantly more protected against SARS-CoV-2 infection than any other group

18 Jan 2022

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

In a new study, a team of researchers estimated the pre-pandemic incidence rates of adverse events of special interest now observed in association with COVID-19 vaccines in Canada.

18 Jan 2022

Antibody responses to COVID-19 mRNA vaccines in a cohort of healthcare workers

Researchers have been investigating the vaccine response of healthcare workers from specific vaccines to different variants.

18 Jan 2022

Immune responses in Omicron breakthrough COVID-19

A recent study examined the question as to whether vaccination protects against Omicron infection by assessing breakthrough infection rates in participants at a superspreader event.

18 Jan 2022

An alternative mouse model of SARS-CoV-2 infection

Recently, a study has shown the possibility of repurposing hACE2 transgenic mice, primarily raised to study SARS-CoV, to support SARS-CoV-2 infection and pathogenesis.

17 Jan 2022

Transmission of Omicron in a quarantine hotel between two vaccinated individuals across a corridor

A recent study has reported a community outbreak of imported SARS-CoV-2 Beta variant, owing to intra-hotel transmission in a DQH.

17 Jan 2022

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Researchers prevent evidence on the efficacy of neutralizing monoclonal antibodies in treating COVID-19.

17 Jan 2022

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Researchers compare the outcomes of the fourth and previous waves of the COVID-19 pandemic in South Africa.

17 Jan 2022

Study shows how sex disparities in COVID-19 mortality varied over time in New York

Researchers analyze the variation in COVID-19 mortality by sex across six different periods during the pandemic in New York.

17 Jan 2022

Vaccine News and Research

Latest Vaccine News and Research

New findings show the potential for language to enhance trust in COVID-19 vaccines

Study reveals the experience of support health care workers from underserved communities during COVID-19

"Nocebo effect" accounts for 76% of all adverse events in the COVID-19 vaccine trial group

Three doses Of Pfizer-BioNTech vaccine could offer sufficient level of protection from Omicron

Parents of children hospitalized in NICU during the pandemic report emotional exhaustion and isolation

Study finds COVID booster maintains strong T cell response against Omicron

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

Dynamics of outbreaks of SARS-CoV-2 variants of concern

Exploring the waning effect of mRNA vaccines against COVID-19 in the elderly

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

Antibody responses to COVID-19 mRNA vaccines in a cohort of healthcare workers

Immune responses in Omicron breakthrough COVID-19

An alternative mouse model of SARS-CoV-2 infection

Transmission of Omicron in a quarantine hotel between two vaccinated individuals across a corridor

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Study shows how sex disparities in COVID-19 mortality varied over time in New York

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in